Double maintains 5 strategies that include JAZZ - Jazz Pharmaceuticals Plc
| Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
|---|---|---|---|---|
| SAND | 0.09% | $2.88B | +71.80% | 0.59% |
| NEUE | -0.22% | $60.89M | +31.91% | 0.00% |
| FYBR | 0.37% | $9.20B | +31.16% | 0.00% |
| ZCMD | 0.40% | $28.79M | -11.91% | 0.00% |
| KGC | 0.63% | $19.13B | +70.94% | 0.77% |
| SSRM | -0.65% | $2.58B | +141.83% | 0.00% |
| UUU | 0.81% | $7.33M | +132.47% | 0.00% |
| FNV | 0.85% | $30.53B | +24.50% | 0.94% |
| VHC | -0.88% | $74.47M | +193.32% | 0.00% |
| MO | -1.07% | $97.92B | +21.81% | 7.02% |
| MOH | 1.09% | $11.87B | -22.90% | 0.00% |
| CNC | 1.09% | $15.25B | -53.58% | 0.00% |
| BULL | 1.26% | $6.21B | +14.89% | 0.00% |
| OR | -1.27% | $5.15B | +57.13% | 0.71% |
| RLMD | 1.36% | $20.83M | -83.66% | 0.00% |
| CYCN | 1.37% | $10.59M | +13.01% | 0.00% |
| AU | 1.43% | $24.15B | +65.64% | 2.14% |
| SRRK | 1.44% | $3.66B | +319.00% | 0.00% |
| ED | 1.46% | $36.39B | +11.91% | 3.34% |
| DG | 1.54% | $25.17B | -9.90% | 2.08% |
Yahoo
Jazz Pharmaceuticals PLC (NASDAQ:JAZZ) is one of the 7 most undervalued pot stocks to buy according to analysts. On June 11, the company presented at the Goldman Sachs 46th Annual Global Healthcare Conference, where it outlined its strategic growth initiatives and acknowledged various challenges. According to the presentation, Jazz Pharmaceuticals reported robust growth in its […]
Yahoo
Current operations chief Renee Gala will succeed Bruce Cozadd at Jazz. Meanwhile, a key study of an Ultragenyx and Mereo drug is continuing past a second interim analysis.
Yahoo
While profitability is essential, it doesn’t guarantee long-term success. Some companies that rest on their margins will lose ground as competition intensifies - as Jeff Bezos said, "Your margin is my opportunity".
Yahoo
Acadia Pharmaceuticals is working on its next-generation Nuplazid and, for CEO Catherine Owen Adams, the journey is personal.
Yahoo
Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the Jazz Board of Directors has unanimously selected Renee Gala, Jazz's President and Chief Operating Officer, as the President and Chief Executive Officer, effective August 11, 2025, when she will also join the Board. She will succeed co-founder, Chairperson and CEO Bruce Cozadd, who informed the Board in December 2024 of his intent to retire as CEO upon the identification of the Company's next leader. This appointment reflects a key
Finnhub
Jazz Pharmaceuticals plc announced that the Jazz Board of Directors has unanimously selected Renee Gala, Jazz's President and Chief Operating Officer, as the President, effective August 11, 2025, when...
| Name | Correlation | AUM | Expense Ratio |
|---|---|---|---|
| CMBS | 0.01% | $456.43M | 0.25% |
| TFLO | 0.13% | $6.73B | 0.15% |
| GLD | -0.22% | $100.91B | 0.4% |
| TIPX | 0.27% | $1.74B | 0.15% |
| GVI | -0.27% | $3.44B | 0.2% |
| AAAU | -0.33% | $1.56B | 0.18% |
| GOVT | -0.38% | $27.40B | 0.05% |
| OUNZ | -0.39% | $1.74B | 0.25% |
| IAU | -0.42% | $47.18B | 0.25% |
| BAR | -0.48% | $1.11B | 0.1749% |
| IBD | 0.53% | $391.63M | 0.43% |
| GLDM | -0.55% | $15.87B | 0.1% |
| SGOL | -0.63% | $5.21B | 0.17% |
| UTEN | -0.67% | $211.64M | 0.15% |
| STXT | 0.74% | $128.89M | 0.49% |
| BOXX | -0.86% | $6.97B | 0.19% |
| IBTP | 0.95% | $143.68M | 0.07% |
| AGZD | 0.99% | $98.57M | 0.23% |
| LGOV | -1.08% | $651.93M | 0.67% |
| BSMW | 1.08% | $107.58M | 0.18% |
| Name | Correlation | AUM | Expense Ratio |
|---|---|---|---|
| XPH | 57.58% | $155.51M | 0.35% |
| MOAT | 56.62% | $12.98B | 0.47% |
| FXH | 56.52% | $891.10M | 0.62% |
| PBE | 56.51% | $233.59M | 0.58% |
| VFLO | 55.16% | $4.46B | 0.39% |
| DSTL | 55.12% | $1.82B | 0.39% |
| FBT | 54.86% | $1.05B | 0.54% |
| RSP | 54.17% | $74.68B | 0.2% |
| JVAL | 54.00% | $532.35M | 0.12% |
| IUS | 53.89% | $639.41M | 0.19% |
| SMOT | 53.82% | $403.05M | 0.49% |
| SIZE | 53.81% | $353.98M | 0.15% |
| IHE | 53.80% | $562.06M | 0.39% |
| FNDX | 53.78% | $18.97B | 0.25% |
| IUSV | 53.70% | $21.36B | 0.04% |
| IWS | 53.68% | $13.65B | 0.23% |
| XLB | 53.50% | $5.60B | 0.09% |
| FLQM | 53.34% | $1.67B | 0.3% |
| JQUA | 53.34% | $6.49B | 0.12% |
| VOOV | 53.30% | $5.57B | 0.1% |
| Name | Correlation | AUM | Expense Ratio |
|---|---|---|---|
| TAIL | -44.58% | $94.90M | 0.59% |
| VIXY | -37.67% | $200.94M | 0.85% |
| VIXM | -35.59% | $22.99M | 0.85% |
| IVOL | -30.16% | $341.06M | 1.02% |
| BTAL | -29.67% | $310.24M | 1.43% |
| FTSD | -22.62% | $233.24M | 0.25% |
| XONE | -21.04% | $629.16M | 0.03% |
| SPTS | -19.11% | $5.78B | 0.03% |
| VGSH | -17.10% | $22.70B | 0.03% |
| FXY | -16.78% | $798.58M | 0.4% |
| SCHO | -15.21% | $10.92B | 0.03% |
| TBLL | -15.11% | $2.12B | 0.08% |
| CLIP | -14.55% | $1.51B | 0.07% |
| UTWO | -13.95% | $376.64M | 0.15% |
| IBTH | -13.72% | $1.62B | 0.07% |
| FXE | -12.82% | $592.85M | 0.4% |
| BILS | -12.42% | $3.80B | 0.1356% |
| STPZ | -12.02% | $443.85M | 0.2% |
| GBIL | -11.72% | $6.37B | 0.12% |
| IBTI | -11.51% | $1.07B | 0.07% |
Current Value
$113.051 Year Return
Current Value
$113.051 Year Return
| Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
|---|---|---|---|---|
| DD | 55.08% | $31.33B | -6.66% | 2.09% |
| RITM | 53.51% | $6.22B | +4.36% | 8.47% |
| AXTA | 52.08% | $6.71B | -13.76% | 0.00% |
| PPG | 49.53% | $26.41B | -11.09% | 2.33% |
| LFUS | 49.17% | $5.73B | -12.71% | 1.23% |
| APTV | 48.78% | $15.35B | -2.46% | 0.00% |
| IFF | 48.52% | $19.09B | -22.42% | 2.15% |
| CTSH | 48.32% | $37.16B | +4.09% | 1.61% |
| LEA | 48.30% | $5.73B | -9.71% | 2.85% |
| LYB | 48.22% | $20.26B | -34.09% | 8.45% |
| ITW | 48.21% | $75.48B | +4.41% | 2.32% |
| VSH | 48.02% | $2.37B | -25.50% | 2.26% |
| NLY | 47.91% | $11.89B | -3.58% | 13.68% |
| VLTO | 47.74% | $25.33B | +4.28% | 0.41% |
| SPGI | 47.41% | $162.59B | +9.86% | 0.71% |
| DOW | 47.08% | $19.97B | -46.97% | 9.72% |
| VSTS | 47.08% | $782.79M | -51.86% | 1.74% |
| ZBRA | 47.05% | $16.42B | -1.43% | 0.00% |
| CEVA | 46.97% | $539.31M | +8.67% | 0.00% |
| TXT | 46.80% | $15.42B | -6.26% | 0.09% |
| Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
|---|---|---|---|---|
| MKTX | -13.42% | $8.15B | -1.09% | 1.39% |
| OSCR | -10.26% | $3.84B | -5.75% | 0.00% |
| DFDV | -8.24% | $361.15M | +2,667.20% | 0.00% |
| CBOE | -6.81% | $24.71B | +36.77% | 1.07% |
| HUSA | -5.82% | $20.46M | -9.15% | 0.00% |
| VSTA | -5.68% | $325.62M | +40.00% | 0.00% |
| DRD | -5.66% | $1.18B | +42.77% | 2.05% |
| STG | -5.12% | $56.15M | +27.66% | 0.00% |
| CREG | -4.22% | $5.73M | -77.49% | 0.00% |
| ALHC | -4.13% | $2.65B | +49.22% | 0.00% |
| BCE | -4.01% | $22.02B | -26.94% | 10.19% |
| LITB | -3.74% | $25.36M | -69.22% | 0.00% |
| KROS | -3.72% | $591.77M | -71.45% | 0.00% |
| VSA | -3.57% | $12.16M | +21.20% | 0.00% |
| AIFU | -3.34% | $17.40M | +87.81% | 0.00% |
| HRTG | -3.08% | $671.31M | +204.64% | 0.00% |
| CIG.C | -3.04% | $2.59B | +19.25% | 0.00% |
| AEM | -2.81% | $60.44B | +59.95% | 1.35% |
| AGI | -2.67% | $11.16B | +51.14% | 0.38% |
| PHYS.U | -2.50% | - | - | 0.00% |
